Magnesium for migraine treatment in adults
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if adding magnesium to a standard migraine medication (prochlorperazine) helps treat migraines more effectively. It could be a good option for adults with migraines who haven't taken these drugs recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with migraines or have headaches with typical migraine features (like throbbing pain, nausea, or one-sided pain).
- You must be able to speak English and give your permission to participate.
- You must not be pregnant or allergic to the study drugs.
- You must not have kidney problems or myasthenia gravis.
- You must not have taken these study drugs within 48 hours before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two doses of intravenous (IV) magnesium to see which is more effective at relieving acute headache pain in the emergency department. It aims to provide a fast and effective treatment option for migraine, tension-type, or cluster headaches.
This study compares natural supplements (nutraceuticals) to standard medications for preventing migraine attacks. It aims to find a gentler, effective option for people with frequent episodic migraines.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
This study tests whether a specific diet change can help reduce migraine frequency. Participants will follow a structured diet plan for several weeks to see if it leads to fewer headache days.
This trial studies a mind-body balance approach to help reduce symptoms and disability from pediatric migraine. You may join if your child has migraine headaches and can follow study routines, including keeping a headache diary.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.